Pulmonary hypertension associated with myeloproliferative disorders: A retrospective study of ten cases

Respiration

Volumn 76, Issue 3, 2008, Pages 295-302

  Guilpain, P ^a   Montani, D ^c   Damaj, G ^a   Achouh, L ^c   Lefrere F ^a   Le Pavec, J ^c   Marfaing Koka, A ^d   Dartevelle, P ^e   Simonneau, G ^c   Humbert, M ^c   Hermine, O ^a,b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d HÔPITAL ANTOINE BÉCLÈRE   (France)

^e CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

Chronic thromboembolic pulmonary hypertension; Essential thrombocythemia; Myeloproliferative disease; Polycythemia vera; Pulmonary hypertension

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; HEART CATHETERIZATION; HEMATOLOGICAL PARAMETERS; HUMAN; LUNG ANGIOGRAPHY; LUNG EMBOLISM; LUNG HEMODYNAMICS; LUNG VENTILATION PERFUSION RATIO; MALE; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTHEMIA;

ADULT; AGED; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; POLYCYTHEMIA VERA; PRIMARY MYELOFIBROSIS; PULMONARY CIRCULATION; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; THROMBOCYTHEMIA, ESSENTIAL;

EID: 53149094005     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112822     Document Type: Article

References (37)

1. Rubin L: Primary pulmonary hypertension. N Engl J Med 1997;336:111-117.
2. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M, Rich S, Fishman A: Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004;43:S5-S12.
3. Sztrymf B, Yaici A, Girerd B, Humbert M: Genes and pulmonary arterial hypertension. Respiration 2007;74:123-132.
4. Humbert M, Nunes H, Sitbon O, Parent F, Hervé P, Simonneau G: Risk factors for pulmonary arterial hypertension. Clin Chest Med 2001;22:459-475.
5. Reisner SA, Rinkevich D, Markiewicz W, Tatarsky I, Brenner B: Cardiac involvement in patients with myeloproliferative disorders. Am J Med 1992;93:498-504.
6. Marvin KS, Spellberg RD: Pulmonary hypertension secondary to thrombocytosis in a patient with myeloid metaplasia. Chest 1993;103:642-644.
7. Hill G, McClean D, Fraser R, Hart D, Crozier I, Snowden J, Gibbons S: Pulmonary hypertension as a consequence of alveolar capillary plugging by malignant megakaryocytes in essential thrombocythaemia. Aust NZ J Med 1996;26:852-853.
8. Nand S, Orfei E: Pulmonary hypertension in polycythemia vera. Am J Hematol 1994;47:242-244.
9. Dingli D, Utz JP, Krowka MJ, Oberg AL, Tefferi A: Unexplained pulmonary hypertension in chronic myeloproliferative disorders. Chest 2001;120:801-808.
10. Garcia-Manero G, Schuster SJ, Patrick H, Martinez J: Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases. Am J Hematol 1999;60:130-135.
11. Di Stefano F: Pulmonary arterial hypertension and chronic myeloproliferative disorders. Am J Respir Crit Care Med 2006;174:616.
12. Murphy S: Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia. Semin Hematol 1999;36:9-13.
13. Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Herve P, Rainisio M, Simonneau G: Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002;40:780-788.
14. Garypidou V, Vakalopoulou S, Dimitriadis D, Tziomalos K, Sfikas G, Perifanis V: Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders. Haematologica 2004;89:245-246.
15. Tefferi A, Solberg LA, Silverstein MN: A clinical update in polycythemia vera and essential thrombocythemia. Am J Med 2000;109:141-149.
16. Polycythemia vera: the natural history of 1,213 patients followed for 20 years. Gruppo Italiano Studio Policitemia. Ann Intern Med 1995;123:656-664.
17. Colombi M, Radaelli F, Zocchi L, Maiolo AT: Thrombotic and hemorrhagic complications in essential thrombocythemia. A retrospective study of 103 patients. Cancer 1991;67:2926-3290.
18. Fenaux P, Simon M, Caulier MT, Lai JL, Goudemand J, Bauters F: Clinical course of essential thrombocythemia in 147 cases. Cancer 1990;66:549-556.
19. Wehmeier A, Daum I, Jamin H, Schneider W: Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients. Ann Hematol 1991;63:101-106.
20. Wehmeier A, Sudhoff T, Meierkord F: Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders. Semin Thromb Hemost 1997;23:391-402.
21. Rostagno C, Prisco D, Abbate R, Poggesi L: Pulmonary hypertension associated with long-standing thrombocytosis. Chest 1991;99:1303-1305.
22. Valla D, Casadevall N, Lacombe C, Varet B, Goldwasser E, Franco D, Maillard JN, Pariente EA, Leporrier M, Rueff B, et al: Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med 1985;103:329-334.
23. De Stefano V, Teofili L, Leone G, Michiels JJ: Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. Semin Thromb Hemost 1997;23:411-418.
24. Jais X, Ioos V, Jardim C, Sitbon O, Parent F, Hamid A, Fadel E, Dartevelle P, Simonneau G, Humbert M: Splenectomy and chronic thromboembolic pulmonary hypertension. Thorax 2005;60:1031-1034.
25. Fedullo PF, Auger WR, Kerr KM, Rubin LJ: Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001;345:1465-1472.
26. Hughes RJ, Jais X, Bonderman D, Suntharalingam J, Humbert M, Lang I, Simonneau G, Pepke-Zaba J: The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study. Eur Respir J 2006;28:138-143.
27. Seyfarth HJ, Hammerschmidt S, Pankau H, Winkler J, Wirtz H: Long-term bosentan in chronic thromboembolic pulmonary hypertension. Respiration 2007;74:287-292.
28. Cortelazzo S, Finazzi G, Ruggeri M, Vestri O, Galli M, Rodeghiero F, Barbui T: Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. N Engl J Med 1995;332:1132-1136.
29. Fruchtman SM, Mack K, Kaplan ME, Peterson P, Berk PD, Wasserman LR: From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera. Semin Hematol 1997;34:17-23.
30. Olschewski H, Simonneau G, Galie N, Higenbottam T, Naeije R, Rubin LJ, Nikkho S, Speich R, Hoeper MM, Behr J, Winkler J, Sitbon O, Popov W, Ghofrani HA, Manes A, Kiely DG, Ewert R, Meyer A, Corris PA, Delcroix M, Gomez-Sanchez M, Siedentop H, Seeger W: Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 2002;347:322-329.
31. Nagaya N, Sasaki N, Ando M, Ogino H, Sakamaki F, Kyotani S, Nakanishi N: Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest 2003;123:338-343.
32. Hughes R, Jais X, Suntharalingam J, Humbert M, Parent F, Simonneau G, Pepke-Zaba J: Current understanding of the role of bosentan in inoperable chronic thromboembolic pulmonary hypertension. Expert Opin Pharmacother 2006;7:1133-1138.
33. Ito H, Adachi Y, Arimura Y, Endo T, Hinoda Y, Imai K: A 25-year clinical history of portopulmonary hypertension associated with latent myeloproliferative disorder. J Gastroenterol 2003;38:488-492.
34. Tefferi A: Myelofibrosis with myeloid metaplasia. N Engl J Med 2000;342:1255-1265.
35. Resten A, Maitre S, Humbert M, Rabiller A, Sitbon O, Capron F, Simonneau G, Musset D: Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease. AJR Am J Roentgenol 2004;183:65-70.
36. Coates GG, Eisenberg B, Dail DH: Tc-99m sulfur colloid demonstration of diffuse pulmonary interstitial extramedullary hematopoiesis in a patient with myelofibrosis. A case report and review of the literature. Clin Nucl Med 1994;19:1079-1084.
37. Dorfmuller P, Perros F, Balabanian K, Humbert M: Inflammation in pulmonary arterial hypertension. Eur Respir J 2003;22:358-363.